Clinical Trial

The Intersectional Viborg Screening Program: Cost-(Effectiveness) of Screening for Diabetes and Cardiovascular Diseases

Study acronym: VISP

Enrolling by Invitation

Summary

This is an intersectional and interdisciplinary screening program in Viborg Municipality, including 67 years old citizens. This observational study will estimate the cost-effectiveness of a combined screening program for the following conditions: Abdominal aortic aneurysm, peripheral arterial disease, carotid plaque, hypertension, arrhythmia, and type-2-diabetes. Furthermore, the incidence of the outlined conditions will be described and so will the result of the intervention initiated (secondary medical prophylaxis, smoking cessation, introduction to nutritionally deficient diet etc.)

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2018-01-09.

Trial Details

NCT Number	NCT03395509
Lead Sponsor	Central Jutland Regional Hospital Collaborators: Odense University Hospital
Conditions	Aging, Aortic Aneurysm, Abdominal, Hypertension, Mass Screening, Peripheral Arterial Disease, Arrythmia, Diabetes, Carotid Atherosclerosis
Enrollment	4,500 participants
Start Date	2014-08-01
Primary Completion	2027-08-01 (estimated)
Study Completion	2029-08-01 (estimated)
Updated on ClinicalTrials.gov	2024-02-01